Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Pulmonary Hypertension, November 2017

Free Subscription


Abstracts

Retrieve all available abstracts of the following 92 articles:
HTML format


 

Single Articles

  1. OGAWA A, Satoh T, Fukuda T, Sugimura K, et al
    Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Results of a Multicenter Registry.
    Circ Cardiovasc Qual Outcomes. 2017;10.
    Abstract    

    Abstract available

  2. AUGER WR, Kim NH
    Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: More Work to Be Done.
    Circ Cardiovasc Qual Outcomes. 2017;10.
    Abstract    



  3. GRADY D, Weiss M, Hernandez-Sanchez J, Pepke-Zaba J, et al
    EXPRESS: Medication and patient factors associated with adherence to pulmonary hypertension targeted therapies.
    Pulm Circ. 2017 Jan 1:2045893217743616. doi: 10.1177/2045893217743616.
    Abstract    



  4. BABU AS, Arena R, Morris NR
    Evidence on Exercise Training in Pulmonary Hypertension.
    Adv Exp Med Biol. 2017;1000:153-172.
    Abstract    

    Abstract available

  5. SU J, Manisty C, Parker KH, Simonsen U, et al
    Wave Intensity Analysis Provides Novel Insights Into Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension.
    J Am Heart Assoc. 2017;6.
    Abstract    

    Abstract available

  6. PARIKH KS, Stackhouse KA, Hart SA, Bashore TM, et al
    Health insurance and racial disparities in pulmonary hypertension outcomes.
    Am J Manag Care. 2017;23:474-480.
    Abstract    

    Abstract available

  7. KACPRZAK A, Szturmowicz M, Burakowska B, Franczuk M, et al
    Sarcoidosis-associated pulmonary hypertension treated with sildenafil - a case report.
    Adv Respir Med. 2017 Oct 30. doi: 10.5603/ARM.a2017.0042.
    Abstract    

    Abstract available

  8. KAYMAZ C, Mutlu B, Kucukoglu MS, Kaya B, et al
    Preliminary results from a nationwide adult cardiology perspective for pulmonary hypertension: RegiStry on clInical outcoMe and sUrvival in pulmonaRy hypertension Groups (SIMURG).
    Anatol J Cardiol. 2017;18:242-250.
    Abstract    

    Abstract available

  9. HOSSEINPOUR AR, Perez MH, Longchamp D, Cotting J, et al
    Age is not a good predictor of irreversibility of pulmonary hypertension in congenital cardiac malformations with left-to-right shunt.
    Congenit Heart Dis. 2017 Oct 25. doi: 10.1111/chd.12545.
    Abstract    

    Abstract available

  10. ASSAD TR, Maron BA, Robbins IM, Xu M, et al
    Prognostic Effect and Longitudinal Hemodynamic Assessment of Borderline Pulmonary Hypertension.
    JAMA Cardiol. 2017 Oct 25. doi: 10.1001/jamacardio.2017.3882.
    Abstract    

    Abstract available

  11. ZHANG W, Zhu T, Wu W, Ge X, et al
    LOX-1 mediated phenotypic switching of pulmonary arterial smooth muscle cells contributes to hypoxic pulmonary hypertension.
    Eur J Pharmacol. 2017;818:84-95.
    Abstract    

    Abstract available

  12. BRUNO JA, Nunes RAB, Gutierrez PS, Aiello VD, et al
    Case 5/2017 - A 28-Year-Old Woman with Cor Pulmonale Due to Pulmonary Hypertension Secondary to Chronic Pulmonary Thromboembolism.
    Arq Bras Cardiol. 2017;109:370-375.
    Abstract    



  13. NAKAMURA H, Kato M, Nakaya T, Kono M, et al
    Decreased haptoglobin levels inversely correlated with pulmonary artery pressure in patients with pulmonary arterial hypertension: A cross-sectional study.
    Medicine (Baltimore). 2017;96:e8349.
    Abstract    

    Abstract available

  14. THOMAS E, Yang J, Xu J, Lima FV, et al
    Pulmonary Hypertension and Pregnancy Outcomes: Insights From the National Inpatient Sample.
    J Am Heart Assoc. 2017;6.
    Abstract    

    Abstract available

  15. CHENG XL, Liu ZH, Gu Q, Ni XH, et al
    Prognostic Value of Pulmonary Artery Compliance in Patients with Pulmonary Arterial Hypertension Associated with Adult Congenital Heart Disease.
    Int Heart J. 2017;58:731-738.
    Abstract    

    Abstract available

  16. BURMAN D
    Sleep Disorders: Sleep-Related Breathing Disorders.
    FP Essent. 2017;460:11-21.
    Abstract    

    Abstract available

  17. COIRIER V, Lescoat A, Fournet M, Cazalets C, et al
    [Screening for pulmonary arterial hypertension in patients with systemic sclerosis: Comparison of DETECT algorithm to decisions of a multidisciplinary team, in a competence centre].
    Rev Med Interne. 2017;38:502-507.
    Abstract    

    Abstract available

  18. PLUCHART H, Khouri C, Blaise S, Roustit M, et al
    Targeting the Prostacyclin Pathway: Beyond Pulmonary Arterial Hypertension.
    Trends Pharmacol Sci. 2017;38:512-523.
    Abstract    

    Abstract available

  19. ALJAHDALI AH, Al-Buainain HM, Skarsgard ED
    Staged closure of a giant omphalocele with amnion preservation, modified technique.
    Saudi Med J. 2017;38:422-424.
    Abstract    

    Abstract available

  20. TALWAR S, Kapoor PM, Narula J, Keshri VK, et al
    Right-to-left shunting through the unidirectional valved patch after closure of ventricular septal defect.
    Ann Card Anaesth. 2017;20:243-244.
    Abstract    

    Abstract available

  21. HIGASA K, Ogawa A, Terao C, Shimizu M, et al
    A burden of rare variants in BMPR2 and KCNK3 contributes to a risk of familial pulmonary arterial hypertension.
    BMC Pulm Med. 2017;17:57.
    Abstract    

    Abstract available

  22. KEMAL HS, Kayikcioglu M, Kultursay H, Vuran O, et al
    Right ventricular free-wall longitudinal speckle tracking strain in patients with pulmonary arterial hypertension under specific treatment.
    Echocardiography. 2017;34:530-536.
    Abstract    

    Abstract available

  23. GORTER TM, Verschuuren EAM, van Veldhuisen DJ, Hoendermis ES, et al
    Right ventricular recovery after bilateral lung transplantation for pulmonary arterial hypertensiondagger.
    Interact Cardiovasc Thorac Surg. 2017;24:890-897.
    Abstract    

    Abstract available

  24. HAMMER MM, Miller WT Jr
    Thoracic Manifestations of Klippel-Trenaunay Syndrome.
    J Thorac Imaging. 2017;32:W5-W6.
    Abstract    

    Abstract available

  25. VIZZA CD, Sastry BK, Safdar Z, Harnisch L, et al
    Efficacy of 1, 5, and 20 mg oral sildenafil in the treatment of adults with pulmonary arterial hypertension: a randomized, double-blind study with open-label extension.
    BMC Pulm Med. 2017;17:44.
    Abstract    

    Abstract available

  26. ANDERSON SM, Wray J, Ralph A, Spencer H, et al
    Experiences of adolescent lung transplant recipients: A qualitative study.
    Pediatr Transplant. 2017;21.
    Abstract    

    Abstract available

  27. RAMOS KJ, Somayaji R, Lease ED, Goss CH, et al
    Cystic fibrosis physicians' perspectives on the timing of referral for lung transplant evaluation: a survey of physicians in the United States.
    BMC Pulm Med. 2017;17:21.
    Abstract    

    Abstract available

  28. SAKATA K, Satoh T, Isaka A, Uesugi Y, et al
    Cardiac dysfunction of pulmonary artery aneurysm in patients with pulmonary arterial hypertension.
    Int J Cardiol. 2017;228:1035-1040.
    Abstract    

    Abstract available

  29. XU XQ, Lv ZC, Liu QQ, Zhao QH, et al
    Direct bilirubin: A new risk factor of adverse outcome in idiopathic pulmonary arterial hypertension.
    Int J Cardiol. 2017;228:895-899.
    Abstract    

    Abstract available

  30. BAMBUL HECK P, Eicken A, Kasnar-Samprec J, Ewert P, et al
    Early pulmonary arterial hypertension immediately after closure of a ventricular or complete atrioventricular septal defect beyond 6months of age.
    Int J Cardiol. 2017;228:313-318.
    Abstract    

    Abstract available

  31. GORTER TM, Hoendermis ES, van Veldhuisen DJ, Voors AA, et al
    Right ventricular dysfunction in heart failure with preserved ejection fraction: a systematic review and meta-analysis.
    Eur J Heart Fail. 2016 Sep 20. doi: 10.1002.
    Abstract    

    Abstract available

  32. MEDVEDOFSKY D, Aronson D, Gomberg-Maitland M, Thomeas V, et al
    Tricuspid regurgitation progression and regression in pulmonary arterial hypertension: implications for right ventricular and tricuspid valve apparatus geometry and patients outcome.
    Eur Heart J Cardiovasc Imaging. 2017;18:86-94.
    Abstract    

    Abstract available

  33. BIGDELIAN H, Sedighi M
    The role of preoperative sildenafil therapy in controlling of postoperative pulmonary hypertension in children with ventricular septal defects.
    J Cardiovasc Thorac Res. 2017;9:179-182.
    Abstract    

    Abstract available

  34. SALA MA, Chen C, Zhang Q, Do-Umehara HC, et al
    JNK2 Upregulates Hypoxia-Inducible Factors and Contributes to Hypoxia-Induced Erythropoiesis and Pulmonary Hypertension.
    J Biol Chem. 2017 Nov 8. pii: jbc.RA117.000440. doi: 10.1074/jbc.RA117.000440.
    Abstract    

    Abstract available

  35. ROHM I, Grun K, Muller LM, Kretzschmar D, et al
    Increased Serum Levels of Fetal Tenascin-C Variants in Patients with Pulmonary Hypertension: Novel Biomarkers Reflecting Vascular Remodeling and Right Ventricular Dysfunction?
    Int J Mol Sci. 2017;18.
    Abstract    

    Abstract available

  36. JINGI AM, Noubiap JJ, Tankeu AT, Mfeukeu-Kuate L, et al
    Prevalence and determinants of pulmonary hypertension in a group of Cameroonian patients without chronic lung disease: a cross-sectional echocardiographic study.
    BMC Res Notes. 2017;10:571.
    Abstract    

    Abstract available

  37. MOUS DS, Buscop-van Kempen MJ, Wijnen RMH, Tibboel D, et al
    Changes in vasoactive pathways in congenital diaphragmatic hernia associated pulmonary hypertension explain unresponsiveness to pharmacotherapy.
    Respir Res. 2017;18:187.
    Abstract    

    Abstract available

  38. MAEDER MT, Nagele R, Rohner P, Weilenmann D, et al
    Pulmonary hypertension in stiff left atrial syndrome: pathogenesis and treatment in one.
    ESC Heart Fail. 2017 Nov 8. doi: 10.1002/ehf2.12234.
    Abstract    

    Abstract available

  39. ZHAO H, Zhang H, Xu X, Wang Y, et al
    Risk factors for perinatal cardiac complications in pregnancy with pulmonary hypertension.
    Pregnancy Hypertens. 2017 Sep 7. pii: S2210-7789(17)30061.
    Abstract    

    Abstract available

  40. KITAGAWA MG, Reynolds JO, Wehrens XHT, Bryan RM Jr, et al
    Hemodynamic and Pathologic Characterization of the TASK-1-/- Mouse Does Not Demonstrate Pulmonary Hypertension.
    Front Med (Lausanne). 2017;4:177.
    Abstract    

    Abstract available

  41. SMUKOWSKA-GORYNIA A, Tomaszewska I, Malaczynska-Rajpold K, Marcinkowska J, et al
    Red Blood Cells Distribution Width as a Potential Prognostic Biomarker in Patients With Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension.
    Heart Lung Circ. 2017 Aug 24. pii: S1443-9506(17)31350.
    Abstract    

    Abstract available

  42. LEVY F, Bohbot Y, Sanhadji K, Rusinaru D, et al
    Impact of pulmonary hypertension on long-term outcome in patients with severe aortic stenosis.
    Eur Heart J Cardiovasc Imaging. 2017 Jun 30. doi: 10.1093.
    Abstract    

    Abstract available

  43. CHUNG K, Strange G, Codde J, Celermajer D, et al
    Left Heart Disease and Pulmonary Hypertension: Are We Seeing the Full Picture?
    Heart Lung Circ. 2017 Oct 20. pii: S1443-9506(17)31444.
    Abstract    

    Abstract available

  44. ADELMANN D, Kronish K, Ramsay MA
    Anesthesia for Liver Transplantation.
    Anesthesiol Clin. 2017;35:491-508.
    Abstract    

    Abstract available

  45. KYLHAMMAR D, Radegran G

    Lakartidningen. 2017;114.
    Abstract    

    Abstract available

  46. GREEN JB, Hart B, Cornett EM, Kaye AD, et al
    Pulmonary Vasodilators and Anesthesia Considerations.
    Anesthesiol Clin. 2017;35:221-232.
    Abstract    

    Abstract available

  47. PETTERSSON H, Akerstrom A, Nordin A, Svenungsson E, et al
    Self-reported physical capacity and activity in patients with systemic sclerosis and matched controls.
    Scand J Rheumatol. 2017;46:490-495.
    Abstract    

    Abstract available

  48. ANGUS JA, Soeding PF, Hughes RJA, Wright CE, et al
    Functional estimation of endothelin-1 receptor antagonism by bosentan, macitentan and ambrisentan in human pulmonary and radial arteries in vitro.
    Eur J Pharmacol. 2017;804:111-116.
    Abstract    

    Abstract available

  49. TANG Y, Yao L, Liu Z, Ma X, et al
    Effect of calcium channel blockers evaluated by cardiopulmonary exercise testing in idiopathic pulmonary arterial hypertension responding to acute pulmonary vasoreactivity testing.
    Pulm Pharmacol Ther. 2017;43:26-31.
    Abstract    

    Abstract available

  50. YUAN P, Chen TX, Pudasaini B, Zhang J, et al
    Sex-specific cardiopulmonary exercise testing indices related to hemodynamics in idiopathic pulmonary arterial hypertension.
    Ther Adv Respir Dis. 2017;11:135-145.
    Abstract    

    Abstract available

  51. ZHANG Z, Wang M, Yang Z, Yang F, et al
    Noninvasive prediction of pulmonary artery pressure and vascular resistance by using cardiac magnetic resonance indices.
    Int J Cardiol. 2017;227:915-922.
    Abstract    

    Abstract available

  52. CHEONG FY, Gower AC, Farber HW
    Changes in gene expression profiles in patients with pulmonary arterial hypertension associated with scleroderma treated with tadalafil.
    Semin Arthritis Rheum. 2017;46:465-472.
    Abstract    

    Abstract available

  53. FREA S, Pidello S, Bovolo V, Iacovino C, et al
    Prognostic incremental role of right ventricular function in acute decompensation of advanced chronic heart failure.
    Eur J Heart Fail. 2016 Mar 16. doi: 10.1002.
    Abstract    

    Abstract available

  54. KAMPERIDIS V, Delgado V, van Mieghem NM, Kappetein AP, et al
    Diagnosis and management of aortic valve stenosis in patients with heart failure.
    Eur J Heart Fail. 2016 Jan 4. doi: 10.1002.
    Abstract    

    Abstract available

  55. GHIO S, Crimi G, Temporelli PL, Traversi E, et al
    Haemodynamic effects of an acute vasodilator challenge in heart failure patients with reduced ejection fraction and different forms of post-capillary pulmonary hypertension.
    Eur J Heart Fail. 2017 Nov 16. doi: 10.1002/ejhf.1067.
    Abstract    

    Abstract available

  56. HANYA S, Yoshii K, Sugawara M
    Study of the Characteristics of Pulmonary Trunk in Pulmonary Hypertension Secondary to Left Heart Disease Using Pressure-Velocity Loops (PU-Loops).
    Ann Vasc Dis. 2017;10.
    Abstract    

    Abstract available

  57. XU S, Xu X, Zhang J, Ying K, et al
    Pulmonary hypertension as a manifestation of mitochondrial disease: A case report and review of the literature.
    Medicine (Baltimore). 2017;96:e8716.
    Abstract    

    Abstract available

  58. CARRETON E, Ceron JJ, Martinez-Subiela S, Tvarijonaviciute A, et al
    Acute phase proteins and markers of oxidative stress to assess the severity of the pulmonary hypertension in heartworm-infected dogs.
    Parasit Vectors. 2017;10.
    Abstract    

    Abstract available

  59. KHARAT A, Duxbury B, Hachull AL, Noble S, et al
    [The place of balloon pulmonary angioplasty in the management of chronic thromboembolic pulmonary hypertension].
    Rev Med Suisse. 2017;13:1980-1984.
    Abstract    

    Abstract available

  60. DIAMANTI E, Baud D, Aubert JD, Nicod LP, et al
    [Pulmonary hypertension and pregnancy].
    Rev Med Suisse. 2017;13:1974-1979.
    Abstract    

    Abstract available

  61. FARAG AA, De Puy FG, Hage FG
    Isolated right ventricular ischemia by SPECT myocardial perfusion imaging in a patient with coronary artery disease and pulmonary hypertension.
    J Nucl Cardiol. 2017 Nov 15. doi: 10.1007/s12350-017-1124.
    Abstract    



  62. NAKANO Y, Okumura N, Adachi S, Shimokata S, et al
    Left ventricular end-diastolic dimension and septal e' are predictors of cardiac index at rest, while tricuspid annular plane systolic excursion is a predictor of peak oxygen uptake in patients with pulmonary hypertension.
    Heart Vessels. 2017 Nov 15. doi: 10.1007/s00380-017-1086.
    Abstract    

    Abstract available

  63. MUSCI RL, De Michele L, D'Agostino C, Colonna P, et al
    Multifactorial Genesis of a Seeming Case of Pulmonary Hypertension.
    J Cardiovasc Echogr. 2017;27:149-152.
    Abstract    

    Abstract available

  64. SAVALE L, Weatherald J, Jais X, Vuillard C, et al
    Acute decompensated pulmonary hypertension.
    Eur Respir Rev. 2017;26.
    Abstract    

    Abstract available

  65. PULLAMSETTI SS, Kojonazarov B, Storn S, Gall H, et al
    Lung cancer-associated pulmonary hypertension: Role of microenvironmental inflammation based on tumor cell-immune cell cross-talk.
    Sci Transl Med. 2017;9.
    Abstract    

    Abstract available

  66. CHEN CM, Lin W, Huang LT, Chou HC, et al
    Human mesenchymal stem cells ameliorate experimental pulmonary hypertension induced by maternal inflammation and neonatal hyperoxia in rats.
    Oncotarget. 2017;8:82366-82375.
    Abstract    

    Abstract available

  67. SEN N
    [Schistosomiasis and pulmonary hypertension].
    Tuberk Toraks. 2017;65:237-244.
    Abstract    

    Abstract available

  68. MEHLER K, Udink Ten Cate FE, Keller T, Bangen U, et al
    An Echocardiographic Screening Program Helps to Identify Pulmonary Hypertension in Extremely Low Birthweight Infants with and without Bronchopulmonary Dysplasia: A Single-Center Experience.
    Neonatology. 2017;113:81-88.
    Abstract    

    Abstract available

  69. BLOK IM, van Riel ACMJ, van Dijk APJ, Mulder BJM, et al
    From bosentan to macitentan for pulmonary arterial hypertension and adult congenital heart disease: Further improvement?
    Int J Cardiol. 2017;227:51-52.
    Abstract    



  70. SUZUKI R, Miyamoto T, Hirayama R, Sakaguchi T, et al
    Primary cardiac leiomyosarcoma causing severe pulmonary hypertension.
    J Card Surg. 2017 Nov 23. doi: 10.1111/jocs.13241.
    Abstract    



  71. O'CONNOR MG, Suthar D, Vera K, Slaughter JC, et al
    Pulmonary hypertension in the premature infant population: Analysis of echocardiographic findings and biomarkers.
    Pediatr Pulmonol. 2017 Nov 23. doi: 10.1002/ppul.23913.
    Abstract    

    Abstract available

  72. SHANG X, Xiao S, Dong N, Lu R, et al
    Assessing right ventricular function in pulmonary hypertension patients and the correlation with the New York Heart Association (NYHA) classification.
    Oncotarget. 2017;8:90421-90429.
    Abstract    

    Abstract available

  73. TELLI G, Tel BC, Yersal N, Korkusuz P, et al
    Effect of intermedin/adrenomedullin2 on the pulmonary vascular bed in hypoxia-induced pulmonary hypertensive rats.
    Life Sci. 2017 Nov 18. pii: S0024-3205(17)30608.
    Abstract    

    Abstract available

  74. KOIKE H, Sueyoshi E, Sakamoto I, Uetani M, et al
    Correlation between lung perfusion blood volume and SPECT images in patients with chronic thromboembolic pulmonary hypertension by balloon pulmonary angioplasty.
    Clin Imaging. 2017;49:80-86.
    Abstract    

    Abstract available

  75. MONDRITZKI T, Boehme P, Schramm L, Vogel J, et al
    New pulmonary hypertension model in conscious dogs to investigate pulmonary-selectivity of acute pharmacological interventions.
    Eur J Appl Physiol. 2017 Nov 20. doi: 10.1007/s00421-017-3761.
    Abstract    

    Abstract available

  76. CHIBANA H, Tahara N, Itaya N, Ishimatsu T, et al
    Pulmonary artery dysfunction in chronic thromboembolic pulmonary hypertension.
    Int J Cardiol Heart Vasc. 2017;17:30-32.
    Abstract    

    Abstract available

  77. DESAI A, Desouza SA
    Treatment of pulmonary hypertension with left heart disease: a concise review.
    Vasc Health Risk Manag. 2017;13:415-420.
    Abstract    

    Abstract available

  78. XIONG PY, Potus F, Chan W, Archer SL, et al
    Models and Molecular Mechanisms of World Health Organization Group 2 to 4 Pulmonary Hypertension.
    Hypertension. 2017 Nov 20. pii: HYPERTENSIONAHA.117.08824.
    Abstract    



  79. MAHMUD E, Behnamfar O, Ang L, Patel MP, et al
    Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension.
    Interv Cardiol Clin. 2018;7:103-117.
    Abstract    

    Abstract available

  80. BHOGAL S, Mukherjee D, Banerjee S, Islam AM, et al
    Current Trends and Future Perspectives in the Treatment of Pulmonary Hypertension: WHO Group II-V.
    Curr Probl Cardiol. 2017 Oct 31. pii: S0146-2806(17)30158.
    Abstract    

    Abstract available

  81. FRANCIS BN, Salameh M, Khamisy-Farah R, Farah R, et al
    Tetrahydrobiopterin (BH4 ): Targeting endothelial Nitric Oxide Synthase as a potential therapy for Pulmonary Hypertension.
    Cardiovasc Ther. 2017 Nov 19. doi: 10.1111/1755-5922.12312.
    Abstract    

    Abstract available

  82. GOMEZ O, Okumura K, Honjo O, Sun M, et al
    HEART RATE REDUCTION IMPROVES BIVENTRICULAR FUNCTION AND INTERACTIONS IN EXPERIMENTAL PULMONARY HYPERTENSION.
    Am J Physiol Heart Circ Physiol. 2017 Nov 16:ajpheart.00493.2017.
    Abstract    

    Abstract available

  83. STAM K, van Duin RWB, Uitterdijk A, Cai Z, et al
    Exercise Facilitates Early Recognition of Cardiac and Vascular Remodeling in Chronic Thrombo-Embolic Pulmonary Hypertension in a Novel CTEPH Swine Model.
    Am J Physiol Heart Circ Physiol. 2017 Nov 22:ajpheart.00380.2017.
    Abstract    

    Abstract available

  84. FRUMP AL, Bonnet S, de Jesus Perez VA, Lahm T, et al
    The emerging role of angiogenesis in adaptive and maladaptive right ventricular remodeling in pulmonary hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2017 Nov 2:ajplung.00374.2017.
    Abstract    

    Abstract available

  85. CHEN R, Zhong W, Shao C, Liu P, et al
    Docosahexaenoic acid inhibits monocrotaline-induced pulmonary hypertension via attenuating endoplasmic reticulum stress and inflammation.
    Am J Physiol Lung Cell Mol Physiol. 2017 Nov 2:ajplung.00046.2017.
    Abstract    

    Abstract available

  86. TANG H, Babicheva A, McDermott KM, Gu Y, et al
    Endothelial HIF-2alpha Contributes to Severe Pulmonary Hypertension by Inducing Endothelial-to-Mesenchymal Transition.
    Am J Physiol Lung Cell Mol Physiol. 2017 Oct 26:ajplung.00096.2017.
    Abstract    

    Abstract available

  87. ZHANG YX, Li JF, Yang YH, Zhai ZG, et al
    Renin-angiotensin system regulates pulmonary arterial smooth muscle cell migration in chronic thromboembolic pulmonary hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2017 Nov 9:ajplung.00515.2016.
    Abstract    

    Abstract available

  88. ROMAN BL, Cuttica MJ
    Classifying Pulmonary Hypertension in Hereditary Hemorrhagic Telangiectasia. Hemodynamics Matter.
    Am J Respir Crit Care Med. 2017;196:1244-1246.
    Abstract    



  89. MICHELAKIS ED
    PVDOMICS Drive the Pulmonary Hypertension Field Into the Precision Medicine Era.
    Circ Res. 2017;121:1106-1108.
    Abstract    



  90. MOROZOWICH ST, Murray AW, Ramakrishna H
    Pulmonary Hypertension in Patients for Transcatheter and Surgical Aortic Valve Replacement: A Focus on Outcomes and Perioperative Management.
    J Cardiothorac Vasc Anesth. 2017 Oct 2. pii: S1053-0770(17)30774.
    Abstract    



  91. VENTETUOLO CE, Hess E, Austin ED, Baron AE, et al
    Sex-based differences in veterans with pulmonary hypertension: Results from the veterans affairs-clinical assessment reporting and tracking database.
    PLoS One. 2017;12:e0187734.
    Abstract    

    Abstract available

  92. SATO T, Tsujino I, Ohira H, Oyama-Manabe N, et al
    Accuracy of echocardiographic indices for serial monitoring of right ventricular systolic function in patients with precapillary pulmonary hypertension.
    PLoS One. 2017;12:e0187806.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;